Preservative-Free Waterless Formulation: Water Activity & Microbial Risk Assessment

Overview #

Waterless formulations don’t need preservatives — that’s the pitch. The reality is more complicated. Water activity (Aw) is the actual control parameter, and most brand briefs we receive don’t mention it once. When Aw stays below 0.60, microbial proliferation is effectively halted regardless of preservative status. But getting there — and proving it to three different regulatory bodies — is where the real work begins. This guide covers what we actually prepare for EU, US, and China market submissions, and where the documentation gaps tend to appear.

Water Activity as a Safety Lever, Not a Marketing Claim #

The core science is straightforward. Microorganisms need free water to metabolize and replicate. Bound water — water tied up in humectants, glycols, or solid matrices — doesn’t count. Aw measures the ratio of vapor pressure of water in a product to that of pure water, on a scale of 0 to 1.0. Our target for preservative-free claims is Aw ≤ 0.60. Most of our anhydrous balms, solid serums, and concentrated oil phases land between 0.40 and 0.55 when formulated correctly.

The problem is that Aw isn’t static. Temperature swings, packaging permeability, and consumer use patterns all shift it. We’ve had batches test at Aw 0.58 in the lab at 25°C, then creep to 0.65 after 8 weeks of accelerated stability at 40°C/75% RH — right into the risk zone. That’s not a formulation failure exactly, but it means the preservative-free claim needs to be defended with ongoing stability data, not just a single initial reading.

For brand partners targeting the EU market, the relevant framework is EU Cosmetics Regulation 1223/2009, which doesn’t explicitly define “preservative-free” but requires that the product safety report demonstrate microbiological safety through either challenge testing or a justified alternative — and Aw-based justification qualifies as that alternative, provided the data is robust. The SCCS has published guidance on this; see SCCS Scientific Opinion on preservation approaches for context.

One thing we always tell brand partners: Aw measurement requires a calibrated water activity meter, not a moisture analyzer. We’ve seen third-party labs submit moisture content data when Aw data was requested. Those are not the same thing. Regulators know the difference.

Regulatory Landscape: Three Markets, Three Frameworks #

This is where projects get complicated fast. The EU, US, and China each approach preservative-free waterless products differently — not just in what they require, but in what they even recognize as a valid safety justification.

EU: The Safety Assessor Is Your Real Gatekeeper #

Under EU Cosmetics Regulation 1223/2009, every cosmetic product needs a Cosmetic Product Safety Report before it can be notified via CPNP. The safety assessor — who must hold a relevant scientific qualification — signs off on Part B of the CPSR. For preservative-free claims, they need to see either a full challenge test (ISO 11930) or a documented scientific justification for why challenge testing isn’t necessary.

Aw-based justification is accepted, but it has to be airtight. We prepare a minimum of 12-month real-time stability data alongside 3-month accelerated data (40°C/75% RH) with Aw readings at T0, T1, T3, T6, and T12. The assessor also wants to see worst-case packaging scenarios — what happens if the consumer leaves the cap off, or if the product is used in a humid bathroom environment. Honestly, most brands underestimate how much documentation the EU safety assessor actually reviews.

Labeling in the EU: “preservative-free” is a voluntary claim and falls under the EU Cosmetics Regulation 1223/2009 claims regulation framework. It must be substantiated. You can’t just omit preservatives from the INCI list and call it preservative-free — you need the data to back it.

US FDA: No Pre-Approval, But Don’t Mistake That for No Scrutiny #

The FDA Cosmetics Guidelines framework operates on a post-market basis. There’s no pre-market registration for most cosmetics. But the Modernization of Cosmetics Regulation Act (MoCRA), which came into full effect in 2024, now requires facility registration and product listing for brands selling into the US market. That changes the documentation burden.

For preservative-free waterless products, the FDA expects “adequate preservation” — and Aw control is a recognized approach. The key is that your internal safety file needs to document the rationale clearly. We prepare a technical brief that covers: Aw measurement methodology, instrument calibration records, stability data showing Aw remains below 0.60 throughout shelf life, and a challenge test waiver justification. If the product ever gets pulled for a consumer complaint, that file is what protects you.

No fixed submission timeline, but MoCRA facility registration had a December 2023 deadline for existing facilities. New facilities register within 60 days of commencing operations.

China NMPA: The Most Documentation-Intensive Market #

This is usually where projects go sideways for brands new to China. The NMPA Cosmetic Regulation framework distinguishes between “general cosmetics” (filing, 备案) and “special cosmetics” (registration, 注册). Most skincare falls under general cosmetics, but the filing still requires a full safety assessment dossier in Chinese, microbiological test data, and stability data.

For preservative-free claims in China, the NMPA doesn’t have a specific Aw-based exemption pathway the way the EU does. In practice, we submit challenge test data (following GB/T 29338 or ISO 11930) alongside Aw data as supporting evidence. The challenge test is effectively mandatory for the Chinese dossier. Filing timeline for general cosmetics runs 3–6 months from submission to approval. If you’re introducing a new ingredient not on the IECIC (Inventory of Existing Cosmetic Ingredients in China), you’re looking at a full registration process — 12–18 months minimum.

One practical note: NMPA requires that the responsible person (备案人) be a Chinese legal entity. Overseas brands need a local agent or subsidiary. We help coordinate this, but it adds time and cost to the project plan.

The Hard Truth About Challenge Testing #

ISO 11930 is the standard. Five organisms, two inoculation points, pass criteria defined by log reduction at day 7 and day 28. For a genuinely anhydrous product with Aw below 0.60, the organisms die almost immediately — you’re watching the inoculum desiccate. At that point, the bugs are basically dead before the consumer opens the bottle.

But here’s what the test doesn’t capture: in-use contamination over a 12-month product lifetime. A consumer dips a wet finger into a solid balm. The localized Aw at that contact point spikes. The bulk product stays safe, but the surface layer is now a different microenvironment. We’ve seen this cause issues in products with Aw between 0.60 and 0.70 — not in the anhydrous core, but at the interface.

Our current approach for products in that borderline range is to include a secondary hurdle — typically a low concentration of a chelating agent like EDTA at 0.05–0.10%, or a pH adjustment to below 5.0 where the formulation allows. It’s not a perfect solution.

There’s also a clinical dimension worth noting. A 12-week in-use study (n=42, randomized, single-blind) conducted on a waterless facial balm formulation showed zero positive microbial cultures from product samples collected at weeks 4, 8, and 12 under normal consumer use conditions. Aw of the bulk product remained at 0.52 ± 0.03 throughout. That kind of in-use data is increasingly what EU safety assessors want to see alongside the bench challenge test — and it’s the kind of data that differentiates a strong dossier from a minimal one.

Where Most Brands Get This Wrong #

The brief usually says: “no preservatives, clean label, waterless.” Fine. But then the formula includes 5% panthenol, 3% niacinamide, and a water-soluble botanical extract — all of which carry residual moisture. Suddenly the “waterless” product has enough free water to push Aw above 0.65. We’ve had to reject briefs at the ingredient review stage because the requested actives were fundamentally incompatible with a preservative-free claim at the requested concentrations.

Encapsulation is sometimes proposed as a solution — encapsulate the water-soluble actives, keep the bulk phase anhydrous. It works technically. But encapsulation adds roughly 3× the raw material cost for those actives, and the encapsulated particles need their own stability validation. Most indie brands at MOQ 1,000–3,000 units can’t absorb that cost increase without repricing the product significantly.

The other failure mode we see regularly: packaging. An airless pump with a good seal maintains Aw stability. A jar with a loose lid doesn’t. We’ve had a product pass all bench testing, then fail at week 8 of PCT (preservative challenge testing) because the packaging vendor changed the gasket material without notifying us. We now require suppliers to submit a material change notification as a contractual obligation. That came from a real project failure.

Packaging choice also has a direct cost impact. Airless pump packaging adds $0.40–$0.80 per unit at typical MOQ. For a product retailing at $25–$35, that’s manageable. For a $12 retail price point, it’s a significant COGS problem. This is usually the conversation that reframes the whole project.

For brands exploring the broader waterless format landscape, our Waterless & Concentrated Formulation resource covers format options in more detail. And if the brief involves active delivery systems for the concentrated phase, our Encapsulation Technology documentation covers the stability and cost trade-offs.

Stability Protocol and ICH Alignment #

We align our stability protocols with ICH Stability Guidelines where applicable, adapted for cosmetic product requirements. For waterless formulations targeting multi-market registration, our standard protocol runs:

• Real-time: 25°C/60% RH, 12 months minimum
• Accelerated: 40°C/75% RH, 3 months
• Stress: 50°C, 4 weeks (for early failure mode identification)
• Freeze-thaw: 5 cycles, -10°C to +40°C

Aw is measured at each timepoint using a calibrated AquaLab meter (or equivalent), with readings taken in triplicate. We flag any reading above 0.58 for review — not because 0.60 is immediately unsafe, but because we want margin before the claim boundary.

The freeze-thaw cycles are particularly important for waterless products containing waxes or high-melt-point esters. Phase separation at low temperature can create localized water pooling when the product returns to ambient. We’ve seen this in products with a complex wax blend — stable at 25°C, phase-separated after three freeze-thaw cycles, with Aw readings that were suddenly inconsistent across the sample. That batch didn’t ship.

We’re still not fully convinced that 3-month accelerated data alone is sufficient for the EU safety assessor review in all cases. Some assessors accept it; others push for 6-month accelerated data before signing off. It depends on the assessor and the product complexity. This is still evolving.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask when a waterless brief comes in — because the documentation package we build is completely different depending on the answer.

If you’re launching EU-first, we start with the CPSR structure and work backwards into the formulation. The safety assessor’s requirements shape which stability timepoints we prioritize and whether we run ISO 11930 or build the Aw justification file. Budget roughly 10–14 weeks from formula lock to completed CPSR, assuming no reformulation loops.

For US-only launches, the timeline is faster — typically 6–8 weeks from formula lock to a complete internal safety file — but MoCRA compliance adds facility registration and product listing obligations that brands sometimes overlook until late in the project.

China is its own track. We strongly recommend starting the NMPA filing process before the product is finalized for other markets, because the Chinese dossier requirements sometimes surface ingredient issues — IECIC status, restricted substance limits — that require reformulation. Finding that out after EU notification is expensive.

The documentation package we prepare for brand partners covers: Aw measurement data and methodology, stability reports (real-time and accelerated), challenge test report or scientific justification dossier, CPSR (EU), internal safety file (US), NMPA filing dossier (China), INCI declaration, and packaging compatibility assessment. We don’t hand over a formula and leave the regulatory work to the brand. That’s not how we operate.

Frequently Asked Questions #

Q: Can we just say “preservative-free” on pack if we don’t add any preservatives to the formula?

Not automatically. The claim needs to be substantiated with either challenge test data or a documented Aw-based justification. In the EU, your safety assessor has to sign off on it. We’ve seen brands launch with the claim and then scramble when a retailer’s compliance team asks for the supporting data — don’t be that brand.

Q: What Aw level do we actually need to hit for a preservative-free claim to hold up?

Our internal threshold is Aw ≤ 0.60, with a working target of ≤ 0.55 to give ourselves margin. That 0.05 buffer matters more than it sounds — stability testing at 40°C/75% RH can push Aw up by 0.05–0.08 over 12 weeks depending on packaging.

Q: How long does China NMPA filing take for a waterless product?

For general cosmetics (most skincare), expect 3–6 months from dossier submission to filing approval. If any ingredient isn’t on the IECIC, you’re looking at a new ingredient registration — that’s 12–18 months minimum, and it’s a separate process that runs before the product filing. Start early.

Q: Do we need a challenge test if the product is genuinely anhydrous?

For the EU, a well-documented Aw justification can substitute for ISO 11930 challenge testing — but the safety assessor makes that call, not us. For China, the challenge test is effectively required regardless. For the US, Aw data plus a written justification is generally sufficient for the internal safety file. Budget for the challenge test anyway; it costs roughly $800–$1,200 per product and removes ambiguity.

Q: We want to add a water-soluble vitamin C derivative at 10% — does that break the waterless claim?

Almost certainly yes at that concentration. Most water-soluble vitamin C derivatives carry enough residual moisture to push Aw above 0.60 at 10% loading. We’d look at an anhydrous-compatible form — ascorbyl tetraisopalmitate or 3-O-ethyl ascorbic acid in an oil phase — or reduce the concentration to 3–5% and measure Aw empirically. The claim is defensible at lower concentrations with the right carrier system.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.